← All trials
NCT06035692
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2023
- Primary completion
- Dec 31, 2023
- Completion date
- Jun 30, 2024
- First posted
- Sep 13, 2023
- Last posted
- Dec 29, 2023
- Enrollment
- 176
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Nanjing Medical UniversityLead sponsor
- Huizhou People's Central HospitalCollaborator
- Nanjing Medical UniversityOverall official - principal investigator
- Shanghai Xuhui District Central HospitalCollaborator
- Nanjing Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.